Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-10-21
DOI
10.1093/infdis/jiz555
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dose-related effectiveness of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia: A Danish nationwide cohort study
- (2019) Freija Verdoodt et al. CLINICAL INFECTIOUS DISEASES
- Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination
- (2019) Lauri E. Markowitz et al. VACCINE
- Ten Years of Human Papillomavirus Vaccination in the United States
- (2018) Lauri E. Markowitz et al. Academic Pediatrics
- Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study
- (2018) Rengaswamy Sankaranarayanan et al. VACCINE
- HPV single-dose vaccination: Impact potential, evidence base and further evaluation
- (2018) Margaret Stanley et al. VACCINE
- Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies
- (2018) Aimée R. Kreimer et al. VACCINE
- Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs
- (2018) Lauri E. Markowitz et al. VACCINE
- Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions
- (2018) Christian Dehlendorff et al. VACCINE
- The impact of bivalent HPV vaccine on cervical intraepithelial neoplasia by deprivation in Scotland: reducing the gap
- (2017) Ross L Cameron et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Prevalence of Human Papillomavirus Among Females After Vaccine Introduction—National Health and Nutrition Examination Survey, United States, 2003–2014
- (2017) Sara E Oliver et al. JOURNAL OF INFECTIOUS DISEASES
- Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial
- (2017) Mahboobeh Safaeian et al. JNCI-Journal of the National Cancer Institute
- Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study
- (2017) Kimberley Kavanagh et al. LANCET INFECTIOUS DISEASES
- Impact of Number of Human Papillomavirus Vaccine Doses on Genital Warts Diagnoses Among a National Cohort of U.S. Adolescents
- (2017) Rebecca B. Perkins et al. SEXUALLY TRANSMITTED DISEASES
- Early evidence of the effectiveness of the human papillomavirus vaccination program against anogenital warts in Manitoba, Canada
- (2017) Karla Willows et al. SEXUALLY TRANSMITTED DISEASES
- Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain
- (2017) Esther Navarro-Illana et al. VACCINE
- Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial
- (2017) Mahboobeh Safaeian et al. JNCI-Journal of the National Cancer Institute
- Impact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis
- (2016) K Cuschieri et al. BRITISH JOURNAL OF CANCER
- Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study
- (2016) Eva Herweijer et al. INTERNATIONAL JOURNAL OF CANCER
- Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women
- (2016) Ole-Erik Iversen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
- (2016) Rengaswamy Sankaranarayanan et al. LANCET ONCOLOGY
- Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices
- (2016) Elissa Meites et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Reduction in Human Papillomavirus Vaccine Type Prevalence Among Young Women Screened for Cervical Cancer in an Integrated US Healthcare Delivery System in 2007 and 2012–2013
- (2015) Eileen F. Dunne et al. JOURNAL OF INFECTIOUS DISEASES
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014
- (2015) Sarah Reagan-Steiner et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
- (2014) K Kavanagh et al. BRITISH JOURNAL OF CANCER
- Promising alternative settings for HPV vaccination of US adolescents
- (2014) Parth D Shah et al. Expert Review of Vaccines
- Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma
- (2014) Eva Herweijer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
- (2013) Dorota M Gertig et al. BMC Medicine
- Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women
- (2013) Simon R. M. Dobson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
- (2013) Amy Leval et al. JNCI-Journal of the National Cancer Institute
- A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
- (2012) John T. Schiller et al. VACCINE
- Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
- (2011) Aimée R. Kreimer et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started